| Ytd | -98.94% | |
| 1y | -99.62% |
| Open | 0.30 | Prev Close | 0.30 | Low | 0.29 | High | 0.30 | Mkt Cap | 5.68M |
| Vol | 285.51K | Avg Vol | 1.46M | EPS | -10.62 | P/E | N/A | Forward P/E | -0.90 |
| Beta | -2.14 | Short Ratio | 1.91 | Inst. Own | 48.13% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-08 | 50-d Avg | 0.64 | 200-d Avg | 9.25 | 1yr Est | 15.00 |
KALA News
Gainers Elutia (NASDAQ:ELUT) stock moved upwards by 17.2% to $0.94 during Thursday's after-mark
Gainers Monte Rosa Therapeutics (NASDAQ:GLUE) stock rose 9.7% to $13.09 during Wednesday's afte
FingerMotion jumped 18.1% premarket after agreeing to buy Newbit Technology for $2.3M cash; NewGenIv
KALA Bio shares surge after hours after signing an LOI to acquire a nationwide telehealth platform.
Gainers Silexion Therapeutics (NASDAQ:SLXN) shares rose 26.8% to $0.32 during Tuesday's pre-mar
KALA Bio, Inc. (NASDAQ:KALA) ("KALA" or the "Company") today announced that on Septe
Gainers Prime Medicine (NASDAQ:PRME) shares increased by 13.0% to $3.47 during Thursday's after
Kala Bio, Inc. (NASDAQ:KALA) ("Kala") and Virotek Inc. ("Virotek") today announced t
Gainers bioAffinity Technologies (NASDAQ:BIAF) shares rose 43.1% to $6.53 during Tuesday's regu
U.S. stocks traded lower this morning, with the Dow Jones index falling more than 300 points on Tues
Gainers bioAffinity Technologies (NASDAQ:BIAF) shares increased by 68.4% to $7.68 during Tuesday
Kala Bio, Inc. (Nasdaq: KALA) ("Kala") and Virotek Inc. ("Virotek"), a CLIA-register
Kala Bio (NASDAQ:KALA) reported quarterly losses of $(21.32) per share. This is a 75.11 percent incr
Kala Bio (NASDAQ:KALA) reported quarterly losses of $(0.14) per share which beat the analyst consens
KALA BIO, Inc. (NASDAQ: KALA) ("KALA BIO" or the "Company"), today announced that it
Kala Bio (NASDAQ:KALA) reported quarterly earnings of $0.86 per share which beat the analyst consens
Undervalued companies in health care sector with low RSI values present buying opportunity: PepGen I
Kala Bio launches BIRA AI agent for biotech research, marking a shift to commercial deployment and a
U.S. stock futures fall 250 points, Highpeak Energy shares drop 7%. Other stocks also down in pre-ma
U.S. stock futures fall 250 points, Highpeak Energy shares drop 7%. Other stocks also down in pre-ma
US stocks mixed, Dow down 300 points. Dow down 0.71%, Nasdaq up 0.21%, S&P 500 down 0.13%. Energ
US stocks traded mixed, with Dow down 0.63% while NASDAQ and S&P 500 rose. Energy shares rose by
Indaptus Therapeutics surged 64.65% in after-hours trading following a major insider investment and
Gainers cbdMD (AMEX:YCBD) shares rose 116.3% to $1.35 during Monday's regular session. The comp